What is an ovarian cancer? Ovarian cancer is a malignancy that attacks the ovaries (ovaries) in women.
Cancer tubafalopii (the tube that connects the uterus and ovaries) and cancer of the peritoneum (abdominal cavity) primary ekstraovarium included in ovarian cancer because biological and clinical characteristics resembling ovarian cancer, although both are very rare.
How is the development of ovarian cancer incidence rates today? The incidence of ovarian cancer is slowly increasing in many developed countries in the past two decades.
Reported and 28.7% of all gynecologic cancers (female reproductive organs) occurs in developed countries and 18.8% in developing countries. The highest incidence rates are found in developed countries, with an average of 10 per 100,000, except in Japan (6.4 per 100,000).
Incident in South America (7.7 per 100,000) is relatively high when compared with the incidence in Asia and Africa. Yes, developed countries accounted for half of the total number of ovarian cancer worldwide.
Around the world, there are 204,000 women diagnosed and 125,000 of them died from the disease. From these figures, 90-95% due to the type of epithelial ovarian cancer. Ovarian cancer is currently ranked as the fifth leading cause of death in women due to cancer (Jemal, 2007).
Treatment of ovarian cancer is mainly done with surgery, followed by platinum-based chemotherapy. However, often times causing clinical remission and to date 80% of patients will experience a recurrence that often lead to progression (worsening) of disease and ends with death.
In general, the life expectancy of patients with ovarian cancer also depend on factors such as low grade or stage, well-differentiated tumors, the general status of the patient well, and younger age.
These factors are categorized as favorable factors. Meanwhile, poor prognostic factors include the type of clear cell and serous histologic, advanced stage, the presence of ascites, suboptimal debulking, high stage, and older age.
Cancer tubafalopii (the tube that connects the uterus and ovaries) and cancer of the peritoneum (abdominal cavity) primary ekstraovarium included in ovarian cancer because biological and clinical characteristics resembling ovarian cancer, although both are very rare.
How is the development of ovarian cancer incidence rates today? The incidence of ovarian cancer is slowly increasing in many developed countries in the past two decades.
Reported and 28.7% of all gynecologic cancers (female reproductive organs) occurs in developed countries and 18.8% in developing countries. The highest incidence rates are found in developed countries, with an average of 10 per 100,000, except in Japan (6.4 per 100,000).
Incident in South America (7.7 per 100,000) is relatively high when compared with the incidence in Asia and Africa. Yes, developed countries accounted for half of the total number of ovarian cancer worldwide.
Around the world, there are 204,000 women diagnosed and 125,000 of them died from the disease. From these figures, 90-95% due to the type of epithelial ovarian cancer. Ovarian cancer is currently ranked as the fifth leading cause of death in women due to cancer (Jemal, 2007).
Treatment of ovarian cancer is mainly done with surgery, followed by platinum-based chemotherapy. However, often times causing clinical remission and to date 80% of patients will experience a recurrence that often lead to progression (worsening) of disease and ends with death.
- Ovarian Cancer Life Expectancy
In general, the life expectancy of patients with ovarian cancer also depend on factors such as low grade or stage, well-differentiated tumors, the general status of the patient well, and younger age.
These factors are categorized as favorable factors. Meanwhile, poor prognostic factors include the type of clear cell and serous histologic, advanced stage, the presence of ascites, suboptimal debulking, high stage, and older age.
Labels:
Medicine,
Ovarian cancer,
Prevent Breast Cancer
Thanks for reading What is ovarian cancer? Part I. Please share...!
0 Komentar untuk "What is ovarian cancer? Part I"